NeuroSense Therapeutics (NRSN) Cash & Current Investments (2020 - 2026)
NeuroSense Therapeutics' Cash & Current Investments came in at $231,000 for Q2 2026, down 65.3% from $666,000 a year earlier.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, NeuroSense Therapeutics' Cash & Current Investments was $166,000, down 95.1% from FY2024.
- Cash & Current Investments carries a five-year compound annual growth rate of -28.6% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $3.38 million in FY2024 (+28.0%), $2.64 million in FY2023 (-81.9%), $14.61 million in FY2022 (+32.1%) and $11.06 million in FY2021.
- The five-year range for quarterly Cash & Current Investments is $166,000 (Q4 2025) to $14.61 million (Q4 2022).
- Year-over-year, Cash & Current Investments increased in 1 of the last five quarters, with an average decline of 54.0%.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2022 (growth of 943.7%), and the weakest in Q4 2025 (a decline of 95.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | NeuroSense Therapeutics | 4.00 Mn | -436,466.80 | - | 231,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 231,000.00 |
| Dec 31, 2025 | 166,000.00 |
| Jun 30, 2025 | 666,000.00 |
| Dec 31, 2024 | 3.38 Mn |
| Sep 30, 2024 | 344,000.00 |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 735,000.00 |
| Dec 31, 2023 | 2.64 Mn |
| Sep 30, 2023 | 4.76 Mn |
| Jun 30, 2023 | 7.09 Mn |
| Mar 31, 2023 | 4.41 Mn |
| Dec 31, 2022 | 7.09 Mn |
| Sep 30, 2022 | 8.44 Mn |
| Jun 30, 2022 | 10.37 Mn |
| Mar 31, 2022 | 13.74 Mn |
| Dec 31, 2021 | 11.06 Mn |
| Dec 31, 2020 | 699,000.00 |
API Access
NeuroSense Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();